Taro Recalls Ibuprofen Oral Suspension Due to Foreign Plastic Particles
Taro Pharmaceuticals is recalling 639,325 bottles of Ibuprofen Oral Suspension USP because they may contain small particles of inert plastic material introduced during manufacturing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves an inert foreign substance (plastic particles) without reported injuries or illnesses, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
Taro Pharmaceuticals U.S.A., Inc. is recalling 639,325 bottles of Ibuprofen Oral Suspension USP, 100 mg/5 mL, One Pint (473 mL), NDC 51672-1385-9. The recall was initiated because the product may contain small particles of an inert plastic material that were introduced during the manufacturing process.
The affected product is distributed nationwide in the U.S.A. The specific lot numbers and expiration dates involved in this recall are listed in the structured product information provided. The product is a prescription-only medication manufactured by Taro Pharmaceuticals Inc. in Brampton, Ontario, Canada, and distributed by Taro Pharmaceuticals U.S.A., Inc. in Hawthorne, NY.
Consumers and healthcare providers should stop using the affected lots of Ibuprofen Oral Suspension USP and contact their pharmacist or Taro Pharmaceuticals for further instructions on how to return the product or obtain a replacement.
The recalled product
- Product
- IBUPROFEN (IBUPROFEN)
- Brand
- IBUPROFEN
- Manufacturer
- Taro Pharmaceuticals U.S.A., Inc.
- Category
- Drug — Prescription Drug
- Affected units
- 639,325
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: J78402968
- J784129698
- Exp 9/19
- K765129698
- K765229698
- K765329698
- K769329698
- K778829698
- K778929698
- Exp 10/19
- A887230568
- A887330568
- A887430568
- Exp 12/19
- B865430568
- B865530568
- B865630568
- B869530568
- B869630568
- Exp 1/20
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 5 recalled by Taro Pharmaceuticals U.S.A., Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same brand · IBUPROFEN
- HighChildren's ibuprofen suspension recalled over gel-like mass and black particles
FDA (Drugs) · 2026-03-25
- HighIbuprofen tablets recalled nationwide due to temperature abuse during manufacturing
FDA (Drugs) · 2022-06-15
- ModerateCardinal Health Recalls Ibuprofen Oral Suspension Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateTaro Recalls Ibuprofen Oral Suspension Due to Foreign Plastic Particles
FDA (Drugs) · 2019-11-06
- ModerateTaro Recalls Children's Ibuprofen Suspension Due to Plastic Particles
FDA (Drugs) · 2019-11-06
Same manufacturer · Taro Pharmaceuticals U.S.A., Inc.
See all →- ModerateHydrocortisone & Acetic Acid Otic Solution Recalled for Potency and Impurity Failures
FDA (Drugs) · 2024-08-21
- ModerateClotrimazole and Betamethasone Topical Cream Recalled for Failed Potency Specifications
FDA (Drugs) · 2022-04-06
- SevereClobetasol Propionate Ointment Recalled for Microbial Contamination
FDA (Drugs) · 2022-01-19
- HighTaro Recalls Nortriptyline Hydrochloride Capsules Due to Manufacturing Deviations
FDA (Drugs) · 2021-02-10
- ModerateTaro Recalls Clotrimazole Cream Due to Unknown Degradation Impurity
FDA (Drugs) · 2020-12-23
Same hazard · foreign substance
See all →- ModerateHeritage Pharmaceuticals Recalls Clindamycin Palmitate Hydrochloride Due to Foreign Particles
FDA (Drugs) · 2026-08-19
- HighPrednisolone Acetate Ophthalmic Suspension Recalled for Foreign Substance
FDA (Drugs) · 2026-07-08
- ModerateCorlanor Ivabradine Tablets Recalled for Foreign Substance Contamination
FDA (Drugs) · 2026-07-01
- LowHydroxyzine Hydrochloride Oral Solution recalled for foreign substance
FDA (Drugs) · 2026-07-01
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01